Editorial

The Challenge of Vaccinating Hospitalized Patients for Influenza and Pneumococcus

Authors: Nausheen Faruqi, MD, Keith M. Ramsey, MD

Abstract

Each year, an estimated 35,000 older Americans die of pneumonia and influenza-like illness.1 These figures have remained constant over the past several decades, despite the availability of vaccines to prevent both influenza and Streptococcus pneumoniae infections. Following reports of deaths due to influenza or pneumonia among older, previously hospitalized patients during their last year of life (ie, among those hospitalized in the prior year, but without vaccination for influenza and pneumococcus), initiatives to vaccinate hospitalized, older patients against influenza and pneumococcus were reported as early as 1983. Fedson and Kessler2 reported that only 2 out of 112 older patients admitted for influenza, pneumonia, or chronic pulmonary diseases had been immunized against influenza or Streptococcus pneumoniae during hospitalizations in the previous 12 months. Subsequently, in 1986, the Centers for Disease Control and Prevention recommended that hospitals provide immunizations for influenza, and for Streptococcus pneumoniae in 1989, prior to discharge.3,4 While physicians agreed in principle to the concept, this was a departure from the historical practice of the physician’s office serving as the primary vaccination site for most patients.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179–186.
 
2. Fedson DS, Kessler HA. A hospital-based influenza immunization program, 1977–78. Am J Public Health 1983;73:442–445.
 
3. Centers for Disease Control. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep 1986;35:317–326, 331.
 
4. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee Pneumococcal Polysaccharide Vaccine. MMWR 1989;38(5):64–68, 73–76.
 
5. Fedson DS, Houck P, Bratzler D. Hospital-based influenza and pneumococcal vaccination: Sutton’s Law applied to prevention. Infect Control Hosp Epidemiol 2000;21:692–699.
 
6. Centers for Disease Control and Prevention: Influenza and pneumococcalvaccination levels among adults aged >65 years – United States. MMWR 1998;47:797–802.
 
7. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729–1735.
 
8. Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004;23:363–368.
 
9. Bakare J, Shrivastava R, Jeevanantham V, et al. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients. South Med J 2006;100:140–144.